Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$579,479
-$424,833 QoQ
Shares Held
8,064
-5.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#764
of 1,408 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $47,524,627 across 7 Drug Manufacturers - Specialty & Generic names. ZTS ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
295,938 | $24,497,747 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,209,068 | $9,575,818 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
49,437 | $8,332,111 | |
| 4 | HROW |
Harrow, Inc.
|
70,748 | $3,004,667 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
48,387 | $837,578 | |
| 6 | VTRS |
Viatris Inc
|
43,906 | $697,227 | |
| 7 | ZTS |
Zoetis Inc.
This page
|
8,064 | $579,479 |
All Filings in ZTS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579,479 | 8,064 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,004,312 | 8,496 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,115,771 | 8,868 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,302,101 | 8,899 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,710,771 | 10,970 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,998,192 | 12,136 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,133,405 | 13,094 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,071,614 | 10,603 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,884,190 | 16,637 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $883,276 | 5,220 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||